Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


6 AIDS Res Hum Retroviruses
5 Clin Infect Dis
1 HIV Med
2 J Acquir Immune Defic Syndr
1 J Am Acad Dermatol
1 J Immunol
8 J Infect Dis
1 J Med Virol
7 J Virol
1 Lancet
2 Lancet Infect Dis
1 N Engl J Med
4 Pediatr Infect Dis J
3 PLoS Med
6 PLoS One
3 Vaccine


  1. REIDY WJ, Rabkin M, Syowai M, Schaaf A, et al
    Patient- and program-level monitoring of differentiated service delivery for HIV: a pragmatic and parsimonious approach is needed.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001723.
    >> Share

  2. NGUYEN VK, Greenwald ZR, Trottier H, Cadieux M, et al
    Incidence of sexually transmitted infections before and after Pre-Exposure Prophylaxis for HIV: a cohort study.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001718.
    >> Share

  3. MCMAHON CN, Petoumenos K, Hesse K, Carr A, et al
    Eleven-year incident glucose disorders in treated HIV-infection. The St Vincent's HIV and Diabetes Study.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001709.
    >> Share

  4. CORDOVA D, Heinze J, Hsieh HF, Mistry R, et al
    Are trajectories of psychosocial risk in adolescence linked to HIV vulnerability in emerging and young adulthood? an eighteen-year longitudinal study.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001717.
    >> Share

  5. COGHILL AE, Schenk JM, Mahkoul Z, Orem J, et al
    Omega-3 decreases interleukin-6 levels in HIV and HHV-8 co-infected patients: results from a randomized supplementation trial in Uganda.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001722.
    >> Share

  6. ALTEKRUSE SF, Shiels MS, Modur SP, Land SR, et al
    Cancer burden attributable to cigarette smoking among HIV-infected people in North America.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001721.
    >> Share

  7. BOSER AS, Bidaud B, Maues S, Guiraud N, et al
    Addressing HIV on the French Guyanese-Brazilian border: no choice but collaboration!
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001727.
    >> Share

  8. MCCOMSEY GA, Lupo S, Parks D, Poggio MC, et al
    Switch from tenofovir disoproxil fumarate combination to dolutegravir plus rilpivirine improves parameters of bone health.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001725.
    >> Share

  9. SADANAND S, Das J, Chung AW, Schoen MK, et al
    Temporal variation in HIV-specific IgG subclass Abs during acute infection differentiates spontaneous controllers from chronic progressors.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001716.
    >> Share

  10. GAO N, Wang W, Wang C, Gu T, et al
    Development of broad neutralization activity in SHIV-infected rhesus macaques after long-term infection.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001724.
    >> Share

  11. NEOGI U, Singh K, Aralaguppe SG, Rogers LC, et al
    Ex vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV-1 non-B subtypes.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001726.
    >> Share

  12. MOUNTFORD J, Octaviana F, Estiasari R, Setiawan DD, et al
    Ex vivo expression of chemokine receptors on cells surrounding cutaneous nerves in patients with HIV-associated sensory neuropathy.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001714.
    >> Share

    AIDS Res Hum Retroviruses

  13. SEANG S, Kelesidis T, Huynh D, Park S, et al
    Low levels of endothelial progenitor cells and their association with systemic inflammation and monocyte activation in older HIV-infected men.
    AIDS Res Hum Retroviruses. 2017 Dec 10. doi: 10.1089/AID.2017.0057.
    >> Share

  14. KONG D, Wang Y, Wang C, Liang S, et al
    Identification of a novel HIV-1 unique recombinant form between B, CRF01_AE and CRF07_BC in men who have sex with men in Guangxi, China.
    AIDS Res Hum Retroviruses. 2017 Dec 10. doi: 10.1089/AID.2017.0259.
    >> Share

  15. TUCKER JD, Zhang A, Zhao Y
    HIV Cure Research Crowdsourcing: An Author Response.
    AIDS Res Hum Retroviruses. 2017 Dec 10. doi: 10.1089/AID.2017.0294.
    >> Share

  16. CARY DC, Peterlin BM
    Natural products and HIV/AIDS.
    AIDS Res Hum Retroviruses. 2017 Dec 10. doi: 10.1089/AID.2017.0232.
    >> Share

  17. RODGERS MA, Vallari AS, Yamaguchi J, Holzmayer V, et al
    ARCHITECT HIV Combo Ag/Ab(R) and RealTime(R) HIV-1 assays detect diverse HIV strains in clinical specimens.
    AIDS Res Hum Retroviruses. 2017 Dec 12. doi: 10.1089/AID.2017.0244.
    >> Share

  18. AMEDEE A, Phillips B, Jensen K, Robichaux S, et al
    Early sites of virus replication after oral SIVmac251 infection of infant macaques: implications for pathogenesis.
    AIDS Res Hum Retroviruses. 2017 Dec 14. doi: 10.1089/AID.2017.0169.
    >> Share


  19. DESAI M, Field N, Grant R, McCormack S, et al
    Recent advances in pre-exposure prophylaxis for HIV.
    BMJ. 2017;359:j5011.
    >> Share

    Clin Infect Dis

  20. RICKLES M, Rebeiro PF, Sizemore L, Juarez P, et al
    Tennessee's In-State Vulnerability Assessment for a 'Rapid Dissemination of HIV or HCV Infection' Event Utilizing Data about the Opioid Epidemic.
    Clin Infect Dis. 2017 Dec 7. pii: 4706246. doi: 10.1093/cid/cix1079.
    >> Share

  21. CROWELL TA, Colby DJ, Pinyakorn S, Fletcher JLK, et al
    Acute Retroviral Syndrome is Associated with High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments.
    Clin Infect Dis. 2017 Dec 7. pii: 4706268. doi: 10.1093/cid/cix1063.
    >> Share

  22. MOORE DJ, Jain S, Dube MP, Daar ES, et al
    Randomized Controlled Trial of Daily Text Messages To Support Adherence to PrEP In At-Risk for HIV Individuals: The TAPIR Study.
    Clin Infect Dis. 2017 Nov 24. pii: 4656156. doi: 10.1093/cid/cix1055.
    >> Share

  23. MOULIGNIER A, Savatovsky J, Assoumou L, Lescure FX, et al
    Silent Cerebral Small-Vessel Disease Twice as Prevalent in Middle-Aged Well-Controlled cART-Treated HIV-Infected Individuals Than HIV-Uninfected Individuals.
    Clin Infect Dis. 2017 Dec 13. pii: 4737216. doi: 10.1093/cid/cix1075.
    >> Share

  24. RAYMOND S, Nicot F, Pallier C, Bellecave P, et al
    Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen.
    Clin Infect Dis. 2017 Dec 13. pii: 4736156. doi: 10.1093/cid/cix1070.
    >> Share

    HIV Med

  25. STIRRUP OT, Copas AJ, Phillips AN, Gill MJ, et al
    Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion.
    HIV Med. 2017 Dec 1. doi: 10.1111/hiv.12567.
    >> Share

    J Acquir Immune Defic Syndr

  26. MORGAN FREIMAN J, Jacobson KR, Muyindike WR, Robert Horsburgh C, et al
    Isoniazid Preventive Therapy for People with HIV who are Heavy Alcohol Drinkers in High TB/HIV Burden Countries: a Risk-Benefit Analysis.
    J Acquir Immune Defic Syndr. 2017 Dec 6. doi: 10.1097/QAI.0000000000001610.
    >> Share

  27. FLYNN PM, Taha TE, Cababasay M, Fowler MG, et al
    Prevention of Hiv-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in Hiv-1-Infected Women with High Cd4 Cell Count (Impaact Promise): A Ran
    J Acquir Immune Defic Syndr. 2017 Dec 11. doi: 10.1097/QAI.0000000000001612.
    >> Share

    J Am Acad Dermatol

  28. TELLO TL, Coggshall K, Yom SS, Yu SS, et al
    Merkel Cell Carcinoma: An Update and Review. Part II: Current and Future Therapy.
    J Am Acad Dermatol. 2017 Dec 8. pii: S0190-9622(17)32758.
    >> Share

    J Immunol

  29. WANG C, Edilova MI, Wagar LE, Mujib S, et al
    Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy.
    J Immunol. 2017 Dec 8. pii: jimmunol.1601254. doi: 10.4049/jimmunol.1601254.
    >> Share

    J Infect Dis

  30. AJAYKUMAR A, Soudeyns H, Kakkar F, Brophy J, et al
    Leukocyte telomere length at birth and during the early life of HIV-exposed uninfected children following in utero exposure to antiretrovirals.
    J Infect Dis. 2017 Dec 8. pii: 4706016. doi: 10.1093.
    >> Share

  31. RANGANATH N, Sandstrom TS, Burke Schinkel SC, Cote SC, et al
    The oncolytic virus, MG1, targets and eliminates latently HIV-1-infected cells: implications for an HIV cure.
    J Infect Dis. 2017 Dec 8. pii: 4706282. doi: 10.1093.
    >> Share

  32. NGOBENI R, Samie A, Moonah S, Watanabe K, et al
    Entamoeba Species in South Africa: Correlations With the Host Microbiome, Parasite Burdens, and First Description of Entamoeba bangladeshi Outside of Asia.
    J Infect Dis. 2017 Oct 8. pii: 4372272. doi: 10.1093.
    >> Share

  33. SIVRO A, McKinnon LR
    Mucosal HIV Shedding During ART.
    J Infect Dis. 2017 Dec 12. pii: 4733302. doi: 10.1093.
    >> Share

  34. HAYASHI K, Dong H, Kerr T, Dobrer S, et al
    Declining Mortality Rates in HIV-Infected People Who Inject Drugs During a Seek-and-Treat Initiative in Vancouver, Canada, 1996-2014: A Prospective Cohort Study.
    J Infect Dis. 2017 Dec 12. pii: 4731720. doi: 10.1093.
    >> Share

  35. RONIT A, Sharma S, Baker JV, Mngqibisa R, et al
    Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study.
    J Infect Dis. 2017 Dec 13. pii: 4736314. doi: 10.1093.
    >> Share

  36. SIEDNER MJ, Hunt PW
    All About the Albumin? Prognostic Capacity of Serum Albumin in Patients With Treated HIV Infection.
    J Infect Dis. 2017 Dec 13. pii: 4736315. doi: 10.1093.
    >> Share

  37. KING CC, Ellington SR, Davis NL, Coombs RW, et al
    Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy.
    J Infect Dis. 2017 Dec 12. pii: 4733301. doi: 10.1093.
    >> Share

    J Med Virol

  38. VERGARA-ORTEGA DN, Sevilla-Reyes EE, Herrera-Ortiz A, Torres-Ibarra L, et al
    J Med Virol. 2017 Dec 13. doi: 10.1002/jmv.25003.
    >> Share

    J Virol

  39. QUALLS ZM, Choudhary A, Honnen W, Prattipati R, et al
    Identification of novel structural determinants in MW965 Env that regulate the neutralization phenotype and conformational masking potential of primary HIV-1 isolates.
    J Virol. 2017 Dec 13. pii: JVI.01779-17. doi: 10.1128/JVI.01779.
    >> Share

  40. SCHOUEST B, Weiler AM, Janaka SK, Myers TA, et al
    Maintenance of AP-2 Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.
    J Virol. 2017 Dec 13. pii: JVI.01822-17. doi: 10.1128/JVI.01822.
    >> Share

  41. COHEN YZ, Lorenzi JCC, Seaman MS, Nogueira L, et al
    Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against clade B clinical isolates produced in peripheral blood mononuclear cells.
    J Virol. 2017 Dec 13. pii: JVI.01883-17. doi: 10.1128/JVI.01883.
    >> Share

  42. CHIKATA T, Van Tran G, Murakoshi H, Akahoshi T, et al
    HLA class I-mediated HIV-1 control in Vietnamese infected with HIV-1 subtype A/E.
    J Virol. 2017 Dec 13. pii: JVI.01749-17. doi: 10.1128/JVI.01749.
    >> Share

  43. MORGER D, Zosel F, Buhlmann M, Zuger S, et al
    The three-fold axis of the HIV-1 capsid lattice is the species-specific binding interface for TRIM5alpha.
    J Virol. 2017 Dec 13. pii: JVI.01541-17. doi: 10.1128/JVI.01541.
    >> Share

  44. JONES AT, Chamcha V, Kesavardhana S, Shen X, et al
    A trimeric HIV-1 envelope gp120 immunogen induces potent and broad anti-V1V2 loop antibodies against HIV-1 in rabbits and rhesus macaques.
    J Virol. 2017 Dec 13. pii: JVI.01796-17. doi: 10.1128/JVI.01796.
    >> Share

  45. HRABER P, Rademeyer C, Williamson C, Seaman MS, et al
    Correction for Hraber et al., "Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments".
    J Virol. 2017;92.
    >> Share


  46. BERNARDO EL, Fuente-Soro L, Lopez-Varela E, Naniche D, et al
    Anonymity in HIV testing: implications for public health.
    Lancet. 2017;390:2546.
    >> Share

    Lancet Infect Dis

  47. MOLINA JM, Charreau I, Chidiac C, Pialoux G, et al
    Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.
    Lancet Infect Dis. 2017 Dec 8. pii: S1473-3099(17)30725.
    >> Share

  48. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015.
    Lancet Infect Dis. 2017 Dec 6. pii: S1473-3099(17)30703.
    >> Share

    N Engl J Med

  49. COHEN SD, Kopp JB, Kimmel PL
    Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med. 2017;377:2363-2374.
    >> Share

    Pediatr Infect Dis J

  50. ARCHARY M, Mcllleron H, Bobat R, La Russa P, et al
    Population Pharmacokinetics of Lopinavir in Severely Malnourished HIV Infected Children and the Effect on Treatment Outcomes.
    Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001867.
    >> Share

  51. SETH A, Malhotra RK, Gupta R, Chandra J, et al
    Effect of Antiretroviral Therapy on Growth Parameters of Children With HIV Infection.
    Pediatr Infect Dis J. 2018;37:85-89.
    >> Share

  52. BAKER AN, Bayer AM, Viani RM, Kolevic L, et al
    Morbidity and Mortality of a Cohort of Peruvian HIV-Infected Children 2003-2012.
    Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001865.
    >> Share

  53. BUCEK A, Leu CS, Benson S, Warne P, et al
    Psychiatric Disorders, Antiretroviral Medication Adherence, and Viremia in a Cohort of Perinatally HIV-Infected Adolescents and Young Adults.
    Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001866.
    >> Share

    PLoS Med

  54. JOHNSON LF, May MT, Dorrington RE, Cornell M, et al
    Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study.
    PLoS Med. 2017;14:e1002468.
    >> Share

  55. KENDALL EA, Schumacher SG, Denkinger CM, Dowdy DW, et al
    Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.
    PLoS Med. 2017;14:e1002472.
    >> Share

  56. SUTHAR AB, Barnighausen T
    Antiretroviral therapy and population mortality: Leveraging routine national data to advance policy.
    PLoS Med. 2017;14:e1002469.
    >> Share

    PLoS One

  57. TOBIN K, Davey-Rothwell MA, Nonyane BAS, Knowlton A, et al
    RCT of an integrated CBT-HIV intervention on depressive symptoms and HIV risk.
    PLoS One. 2017;12:e0187180.
    >> Share

  58. ZINGMOND DS, Arfer KB, Gildner JL, Leibowitz AA, et al
    The cost of comorbidities in treatment for HIV/AIDS in California.
    PLoS One. 2017;12:e0189392.
    >> Share

  59. FLYNN AG, Anguzu G, Mubiru F, Kiragga AN, et al
    Socioeconomic position and ten-year survival and virologic outcomes in a Ugandan HIV cohort receiving antiretroviral therapy.
    PLoS One. 2017;12:e0189055.
    >> Share

  60. COETZEE J, Hunt G, Jaffer M, Otwombe K, et al
    HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study.
    PLoS One. 2017;12:e0188606.
    >> Share

  61. CEVALLOS CG, Jones LR, Pando MA, Carr JK, et al
    Genomic characterization and molecular evolution analysis of subtype B and BF recombinant HIV-1 strains among Argentinean men who have sex with men reveal a complex scenario.
    PLoS One. 2017;12:e0189705.
    >> Share

  62. JAGDAGSUREN D, Hayashida T, Takano M, Gombo E, et al
    The second molecular epidemiological study of HIV infection in Mongolia between 2010 and 2016.
    PLoS One. 2017;12:e0189605.
    >> Share


  63. HERBECK JT, Peebles K, Edlefsen PT, Rolland M, et al
    HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine.
    Vaccine. 2017 Dec 11. pii: S0264-410X(17)31731.
    >> Share

  64. HABER P, Moro PL, Ng C, Lewis PW, et al
    Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
    Vaccine. 2017 Dec 11. pii: S0264-410X(17)31722.
    >> Share

  65. GOTTLIEB SL, Giersing BK, Hickling J, Jones R, et al
    Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017.
    Vaccine. 2017 Dec 7. pii: S0264-410X(17)31492.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016